Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations

J Neurol. 2011 Dec;258(12):2260-7. doi: 10.1007/s00415-011-6110-1. Epub 2011 May 29.

Abstract

The data regarding whether parkin genotype attributes phenotypic variation are conflicting. Since the incidence of parkin mutations is very low in patients with an age at onset (AAO) of >40 years, previous studies have unfairly compared phenotypes of two early onset Parkinson's disease (EOPD) groups with different AAOs. Thus, we compared the clinical features between patients with and without parkin mutations in EOPD with an AAO of ≤40 years. Of the 124 patients with EOPD with an AAO of ≤40 years who were recruited and screened for parkin mutations, 84 completed assessments for comparison of the phenotype according to parkin genotype. Fourteen of the 84 subjects carried two parkin mutations; 6, a single mutation; and 64, no mutations. Patients with two mutations had significantly younger AAOs, longer duration of PD, and more common family history than patients without parkin mutations. Otherwise, motor and nonmotor symptoms did not differ between them. Subgroup analysis of EOPD with an AAO of ≤35 years revealed similar results. Phenotype of EOPD may depend on early AAOs rather than presence of parkin mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mental Disorders / epidemiology*
  • Mental Disorders / etiology
  • Motor Skills Disorders / epidemiology*
  • Motor Skills Disorders / etiology
  • Mutation*
  • Parkinson Disease / complications*
  • Parkinson Disease / genetics
  • Phenotype
  • Sensation Disorders / epidemiology*
  • Sensation Disorders / etiology
  • Sleep Disorders, Intrinsic / epidemiology*
  • Sleep Disorders, Intrinsic / etiology
  • Ubiquitin-Protein Ligases / genetics*
  • Young Adult

Substances

  • Ubiquitin-Protein Ligases
  • parkin protein